Trump's Hair Loss Drug Vanishes from Medical Records, Sparking Health Concerns

Finasteride, a hair-loss medication linked to serious side effects, has mysteriously vanished from President Donald Trump's medical records, igniting speculation about his health status.

This drug, commonly known as Propecia, was previously disclosed by Trump's primary doctor in 2017 as part of his treatment regimen. The absence of this medication from all medical disclosures since Trump returned to office last January raises eyebrows.

The latest health report, released in June, failed to mention finasteride, despite the White House claiming that all "clinically relevant" medications were included. They insisted that no significant medical issues or procedures were omitted.

Administration representatives have not clarified whether the removal of finasteride from the documentation indicates that Trump has ceased taking the drug. This lack of transparency fuels concerns about the president's health.

Potential side effects of finasteride include breast enlargement, sexual dysfunction, and depression. The implications of these risks are significant, especially for a nearly 80-year-old individual.

Columbia University psychiatrist Robert Klitzman expressed that the administration's silence on Trump's finasteride use raises serious transparency issues regarding his health. "It raises significant questions of what else is possibly not being revealed," Klitzman stated.

In 2015, Trump's former physician, Dr. Harold Bornstein, claimed Trump would be the "healthiest individual ever elected to the presidency." However, Bornstein later admitted that Trump had dictated that letter.

During his second term, Trump has confirmed only three medical appointments amid scrutiny over his swollen ankles, hand bruising, and erratic behavior. In October, he acknowledged one appointment involved an MRI but refused to specify the area examined, insisting it was not his brain.

"It wasn't the brain because I took a cognitive test and I aced it," Trump claimed. He frequently cites his Montreal Cognitive Assessment results as evidence of his mental acuity, although experts note that the test is designed to detect cognitive decline.

Trump's assertion of completing the cognitive test three times has alarmed specialists like Dr. John Gartner, who suggests such repeated testing could indicate dementia monitoring rather than routine evaluation, especially given Trump's recent public episodes of disorientation and hostility.

A three-page medical summary released on Friday night declared Trump in "excellent health," yet healthcare professionals remain skeptical due to the lack of supporting evidence.

The document did not address a previously reported neck rash but acknowledged bruising on his hands, which the White House attributed to aspirin use for heart health.